Gynecological Health

DotLab Begins Enrollment in a Multi-Center Cohort Study for Its Non-Invasive Test for Endometriosis

DotLab, a healthcare technology company at the forefront of research and development to combat women’s health conditions, today announced the initiation of EMPOWER, a multi-center cohort study for endometriosis. The EMPOWER Study is designed to support future development activities for DotLab’s non-invasive test to aid in the diagnosis of active endometriosis. Last year, DotLab announced the publication of data in the American Journal…

Chlamydia and Gonorrhea Prevention: Evofem Announces Publication in American Journal of Obstetrics and Gynecology of AMPREVENCE Study of EVO100

Evofem has recently announced publication of the pivotal manuscript from the AMPREVENCE clinical trial in the highly respected American Journal of Obstetrics and Gynecology (AJOG). This double-blinded, placebo-controlled, multicenter study of EVO100 met its primary and secondary efficacy endpoints with statistically  significant reductions in the risk of chlamydia and gonorrhea infections in women at high risk of infection. “We believe publication of this important manuscript in such a prestigious…

Femtech Startup Syrona Health Launches ‘SORA’, a New Mobile Virtual Health Assistant for Women Living with Endometriosis

Just like many other conditions in the women’s health space endometriosis is under researched, underserved and underfunded although it affects around 170 million women globally. The most common symptom of endometriosis is pelvic pain, which often correlates to the menstrual cycle. As the symptoms of the disease are not easily recognized – by providers and affected women – many experience a significant…

The American Board of Obstetrics and Gynecology (ABOG) Announces the Appointment of Three New Board of Directors Members

The American Board of Obstetrics and Gynecology (ABOG) has recently announced the appointment of three new subspecialty Division Chairs and four new Division Members. They all will begin their terms on July 1, 2021. The Chairs will also serve as ex-officio subspecialty representatives on the Board of Directors.  The American Board of Obstetrics and Gynecology (ABOG) is an independent, non-profit organization that certifies obstetricians and gynecologists in the United States. Founded in 1927, ABOG…

Detroit Medical Center Huron Valley-Sinai Hospital Introduces Sonata, a New, Incision-Free Treatment for Uterine Fibroids

Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that Detroit Medical Center (DMC) Huron Valley-Sinai Hospital is the first hospital in Michigan to introduce the Sonata Procedure. Fibroids are benign growths in or around the uterus, with about 70 percent of white women and more than 80 percent of black women…

Runway Growth Capital Announces a Senior Secured Term Loan of $50M to Gynesonics for Their Intrauterine Fibroid Ablation System

Runway Growth Capital, a provider of growth loans to both venture and non-venture backed companies seeking an alternative to raising equity, announced today the closing of a senior secured term loan of $50 million to Gynesonics, a healthcare company focused on advancing women’s health by developing minimally invasive, incision-free, uterus-preserving, transcervical technologies for diagnostic and therapeutic applications. Gynesonics has developed and has received FDA clearance for…

Rhia Ventures Invests in OCON Healthcare’s Ballerine, the First 3D Spherical Copper Intrauterine Contraceptive

Rhia Ventures has invested in Israel-based OCON Healthcare to assist the US launch of Ballerine, the first and only 3D spherical copper IUB (Intrauterine Ball). Ballerine’s unique shape reduces irritation to the endometrium with fewer malpositions and perforations, which are significant drawbacks associated with current T-shaped IUDs. The financing will also help expand Phase II clinical trials for OCON’s SEAD product, which offers point-of-care…

UTI Awareness Day 2020: An Interview with Uqora Founder Jenna Ryan

September is PCOS Awareness Month, October dedicated to breast cancer awareness and this November aka Bladder Health Awareness Month we are looking to femtech company Uqora, who have declared today, Nov 21, National UTI Awareness Day to put a spotlight on this major health issue that affects millions of women. Uqora makes innovative products for urinary health. It all started in 2014,…